Ireland· IE-PA-PA0822/228/001
NIPENT 10 mg powder for solution for injection, powder for solution for infusion
A pentostatin product containing pentostatin, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pentostatin is registered in 5 of 19 countries.
Countries holding a registration under ATC L01XX08 (pentostatin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Pentostatin · ATC L01XX08
5 / 19 countries
- Franceprice
- Germany
- Ireland
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Pentostatin
- Manufacturer
- Pfizer Healthcare Ireland Unlimited Company
- Country
- Ireland (IE)
- ATC code
- L01XX08
- ATC class
- Pentostatin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0822/228/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for pentostatin.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentostatin · interactions on record
130 records
- 31 severe
- 83 moderate
- 16 minor
Most severe, free to view
- CladribineL01BB04severe
- FludarabineL01BB05severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentostatin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainNIPENT 10 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONPfizer S.L.
- United StatesNipentHospira, Inc.
- GermanyNipentPfizer Pharma Gmbh
- FranceNIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusionPFIZER HOLDING FRANCE
- United KingdomNipent 10mg powder for solution for injection vialsPfizer Ltd
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Germany · Nipent
- Spain · Nipent
- France · Nipent
- United Kingdom (Northern Ireland) · Nipent
- Greece · Nipent
- Italy · Nipent
- Malta · Nipent
- Portugal · Nipent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/911f7544-39fe-40fd-a942-fb87cfeb8bfa GET /v1/drugs/911f7544-39fe-40fd-a942-fb87cfeb8bfa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L01XX",
"L01XX08"
],
"strength": null,
"pa_number": "PA0822/228/001",
"substances": [
"Pentostatin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "21/04/1993",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pentostatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.